Per Reuters: During his first term, a court blocked his proposed international reference pricing program. The difference in this term is the admin spices up EO

Per Reuters: During his first term, a court blocked his proposed international reference pricing program. The difference in this term is the admin spices up EO's by flagrantly defying court orders. I don't see how the magic sauce helps here. When a court strikes down this EO, US drug makers carry on as ever. And the admin defies - what? https://www.reuters.com/business/healthcare-pharmaceuticals/trump-sign-order-drug-prices-early-next-week-politico-reports-2025-05-07/ https://www.reuters.com/business/healthcare-pharmaceuticals/...